(Q51568719)

7 April 2018

title

Japanese gastric cancer treatment guidelines 2010 (ver. 3). (English)

1 reference

7 April 2018

author name string

Japanese Gastric Cancer Association

series ordinal

1

1 reference

7 April 2018

publication date

1 June 2011

1 reference

7 April 2018

published in

Gastric Cancer

1 reference

7 April 2018

volume

14

1 reference

7 April 2018

issue

2

1 reference

7 April 2018

page(s)

113-123

1 reference

7 April 2018

https://scigraph.springernature.com/pub.10.1007/s10120-011-0042-4

exact match

0 references

cites work

Stomach-partitioning gastrojejunostomy for unresectable gastric carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0042-4

Randomized controlled trial comparing gastrectomy plus chemotherapy with chemotherapy alone in advanced gastric cancer with a single non-curable factor: Japan Clinical Oncology Group Study JCOG 0705 and Korea Gastric Cancer Association Study KGCA01.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0042-4

Japanese Classification of Gastric Carcinoma - 2nd English Edition -

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0042-4

Therapeutic value of lymph node dissection in advanced gastric cancer with macroscopic duodenum invasion: is the posterior pancreatic head lymph node dissection beneficial?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0042-4

Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0042-4

Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0042-4

Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0042-4

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0042-4

Initial or delayed chemotherapy with best supportive care in advanced gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0042-4

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0042-4

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0042-4

Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0042-4

Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0042-4

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0042-4

Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: five-year results of a randomized prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0042-4

A randomized controlled trial comparing open vs laparoscopy-assisted distal gastrectomy for the treatment of early gastric cancer: an interim report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0042-4

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0042-4

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0042-4

Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0042-4

Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0042-4

Value of palliative resection in gastric cancer

21 January 2018

1 reference

12 December 2020

Japanese classification of gastric carcinoma: 3rd English edition

1 reference

12 December 2020

D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer

1 reference

12 December 2020

Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma: Japan clinical oncology group study JCOG 0110-MF

1 reference

12 December 2020

Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial

1 reference

12 December 2020

Randomized Phase III study of 5-fluorouracil continuous infusion vs. sequential methotrexate and 5-fluorouracil therapy in far advanced gastric cancer with peritoneal metastasis (JCOG0106).

1 reference

12 December 2020

10.1007/S10120-011-0042-4

Identifiers

DOI

1 reference

7 April 2018

PubMed ID

21573742

1 reference

7 April 2018